Next Generation News and Research

RSS

In developing countries young children have better survival chances if their mothers are taller

Each centimeter/inch counts for women in developing countries. This is the outcome of research by Christiaan Monden of Tilburg University and Jeroen Smits of Radboud University Nijmegen in the Netherlands, which was recently published online in American Journal of Human Biology.

3 Feb 2009

New imaging technique distinguishes breast cancer cells from normal cells

A team of researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have developed a rapid, automated image screening process to distinguish breast cancer cells from normal cells.

2 Feb 2009

Advances in nanotechnology point to next generation of prostheses

The futuristic technology of the Six Million Dollar Man - specifically a part metal and part flesh human being - won't be exclusive to Hollywood anymore.

29 Jan 2009

Although our genetics differ significantly, we all look alike...

The genetic variation within a species can be significant, but very little of that variation results in clear differences in morphology or other phenotypes.

27 Jan 2009

Survivorship care after breast cancer, call for more action

As the nation's growing population of breast cancer survivors ages, many patients will likely develop common chronic illnesses like diabetes and heart disease, and they'll need specialized care to balance those problems with the late effects of cancer therapies they received.

19 Jan 2009

Researchers find molecular origin of blood stem cells

A research team led by Nancy Speck, PhD, Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo.

12 Jan 2009

Researchers find genes that fuse in cancer

Using new technologies that make it easier to sequence the human genome, researchers at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade places with each other.

12 Jan 2009

VistaGen, WARF sign license agreement for human embryonic stem cell technology

VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.

18 Dec 2008

Next generation intermittent urinary catheters

Rochester Medical Corporation (NASDAQ:ROCM) today announced the introduction of Magic3(TM), its new line of intermittent urinary catheters.

18 Dec 2008

3.6 million Americans living with active, undiagnosed psoriasis, unaware of associated risks

Armed with research concluding that psoriasis is associated with an increased risk of heart attacks and other cardiovascular conditions, Joel M. Gelfand, MD, MSCE, Assistant Professor of Dermatology at the University of Pennsylvania School of Medicine and colleagues released an editorial consensus in the American Journal of Cardiology today¸ calling for psoriasis patients to be educated about and screened for cardiovascular risk factors.

15 Dec 2008

Breast cancer genome shows instability of cancer

A newly published genome sequence of a breast cancer cell line reveals a heavily rearranged genetic blueprint involving breaks and fusions of genes and a broken DNA repair machinery, said researchers at Baylor College of Medicine in a report that appears online in the journal Genome Research.

15 Dec 2008

Calls for a change in alcohol culture and promotion

According to a new report from the University of Wollongong in New South Wales, 90% of 12 to 17-year-olds in the state have used alcohol; the report also reveals that the level of risky drinking by adults has decreased from 50% to 30% in men and 37 to 27% in women.

14 Dec 2008

Neither vitamin E nor selenium reduce risk of prostate cancer

In perhaps the largest cancer chemoprevention trial ever conducted, researchers have found that supplementation with vitamin E or selenium, alone or in combination, was not associated with a lower risk of prostate cancer or other cancers.

10 Dec 2008

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor, Inc. presented results Sunday at the 50th Annual Meeting of the American Society of Hematology from pre-clinical studies evaluating XmAb 5574, a monoclonal antibody engineered using Xencor's XmAb Fc technologies that targets the antigen CD19.

10 Dec 2008

Low-income settings require local guideline development for childhood illness

The next generation of case management guidelines for childhood illness need to be more locally informed, rather than relying on those centrally generated by organizations like the World Health Organization (WHO), argues a new essay published in the open access journal PLoS Medicine.

8 Dec 2008

Daiichi Sankyo starts trial of investigational factor Xa inhibitor for atrial fibrillation

Daiichi Sankyo Company, Limited, has announced that it has initiated its pivotal Phase III trial for DU-176b, an investigational oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely by Daiichi Sankyo.

7 Dec 2008

Extraordinary immune cells may hold the key to managing HIV

People who manage to control HIV on their own are providing scientists with valuable information about how the immune system eliminates virus-infected cells.

5 Dec 2008

Intradigm issued new RNAi therapeutics patent

Intradigm Corporation has announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing."

3 Dec 2008

Magnetic imaging devices may damage cochlear implants

Patients with cochlear implants may want to steer clear of certain magnetic imaging devices, such as 3T MRI machines, because the machines can demagnetize the patient's implant, according to new research published in the December 2008 issue of Otolaryngology - Head and Neck Surgery.

1 Dec 2008

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.

1 Dec 2008